Fennec Provides Corporate Update and Announces Second Quarter 2017 Results
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - Aug 11, 2017) - Fennec Pharmaceuticals Inc. (TSX:FRX) (OTCQB:FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced …